Hong Kong Island, Hong Kong, China Harvest Global Investments is the famous VC, which was founded in 2008. The main department of described VC is located in the Central. The fund was located in Asia if to be more exact in Hong Kong. Harvest Global Investments appeared to be a CVC structure as part of the corporation.
Among the most popular portfolio startups of the fund, we may highlight JD Digits, Hua Medicine, Qiniu. We can highlight the next thriving fund investment areas, such as Medical, B2C. For fund there is no match between the country of its foundation and the country of its the most frequent investments - China. The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup needs to be aged 6-10 years to get the investment from the fund.
The fund is constantly included in less than 2 investment rounds annually. When the investment is from Harvest Global Investments the average startup value is more than 1 billion dollars. The top amount of exits for fund were in 2018. Opposing the other organizations, this Harvest Global Investments works on 12 percentage points less the average amount of lead investments. Speaking about the real fund results, this VC is 47 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of more than 100 millions dollars. The top activity for fund was in 2018.
Besides them, we counted 1 critical employee of this fund in our database.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Harvest Global Investments, startups are often financed by Qiming Venture Partners, Venrock, WuXi Healthcare Ventures. The meaningful sponsors for the fund in investment in the same round are FutureCap, Telstra Ventures, ShenZhen GTJA Investment Group. In the next rounds fund is usually obtained by YF Capital (Yunfeng Capital), WuXi AppTec, Venrock.
| Fund Name | Location |
| Calumet Venture Fund | Madison, United States, Wisconsin |
| China Asset Management | Beijing, Beijing, China |
| Fertitta Capital | California, United States, West Hollywood |
| Gladium | Gothenburg, Sweden, Vastra Gotaland |
| Ideal Ventures | - |
| JDRF (The Juvenile Diabetes Research Foundation) | New York, New York, United States |
| John Nurminen Oy | Finland, Helsinki, Southern Finland |
| KAR Global | Carmel, Indiana, United States |
| Leaguer Group | China, Guangdong, Shenzhen |
| Mintian Capital | - |
| MiraeAsset Financial Group | - |
| Momentum Equity Partners | Boston, Massachusetts, United States |
| Ocean Road Partners | California, United States, Venice |
| OSJL LLC | - |
| Plastilin | - |
| RGB Capital | California, San Diego, United States |
| Rittenhouse Ventures | Pennsylvania, Philadelphia, United States |
| Silver Tiger Capital | Beijing, Beijing, China |
| TWJ Capital | Connecticut, Stamford, United States |
| Zagat | New York, New York, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Xingji Meizu | $309M | 16 Nov 2023 | Wuhan, Hubei, China | ||
XINGYUN GROUP | $600M | 19 Apr 2021 | Futian District, Guangdong Province, China | ||
XQIAO | $21M | 16 Oct 2018 | Shanghai, China | ||
Viroad Biotechnology | $14M | 14 Sep 2018 | Shijiazhuang City, Hebei, China | ||
| 03 Sep 2018 | China, Beijing | ||||
Mabworks | $41M | 25 Jan 2017 | China, Beijing | ||
Hua Medicine | $50M | 21 Apr 2016 | Shanghai, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Xingji Meizu | $309M | 16 Nov 2023 | Wuhan, Hubei, China | ||
XINGYUN GROUP | $600M | 19 Apr 2021 | Futian District, Guangdong Province, China | ||
XQIAO | $21M | 16 Oct 2018 | Shanghai, China | ||
Viroad Biotechnology | $14M | 14 Sep 2018 | Shijiazhuang City, Hebei, China | ||
| 03 Sep 2018 | China, Beijing | ||||
Mabworks | $41M | 25 Jan 2017 | China, Beijing | ||
Hua Medicine | $50M | 21 Apr 2016 | Shanghai, China |
